Latest News

Tech encourages HIV prevention among women


 

Access to technology, particularly cellphones, is tied to a higher awareness of pre-exposure prophylaxis (PrEP) in women, according to survey results presented at the Association of Nurses in AIDS Care 2023 Annual Meeting.

Those with limited access to technology, older women, and women who had been incarcerated were also less likely to be aware of their medication options.

Researchers collected responses from 206 women in New York and Philadelphia by computer survey. The women were HIV negative and eligible to receive medication but were not currently taking any.

Most participants were Black (61%) or Hispanic (24%), and the average age of participants was 39 years. Nearly 60% of the group reported they were not aware of PrEP.

Younger women, Hispanic women, women who had not been incarcerated, and women with access to technology were most likely to be aware that they could take medication to prevent HIV.

“Women who utilized their cell phones for activities such as texting, emailing, watching videos, playing games, downloading apps, and accessing social media were more likely to be aware of PrEP,” point out the researchers led by Su Kyung Kim, PhD, WHNP-BC, an assistant professor at Thomas Jefferson University, Philadelphia.

These findings could help direct efforts to increase awareness among women where uptake has remained low, the researchers report. “Mobile technologies, in particular, offer a nimble, customizable, and accessible way to reach this target population and increase awareness of PrEP.”

A version of this article first appeared on Medscape.com.

Recommended Reading

Integrase inhibitors and gestational weight gain: Should women worry?
MDedge ObGyn
HPV infection in pregnancy higher among women living with HIV
MDedge ObGyn
As STDs proliferate, companies rush to market at-home test kits. But are they reliable?
MDedge ObGyn
Opt-out HIV testing in EDs can help identify undiagnosed cases
MDedge ObGyn
Future HIV PrEP innovations aim to address adherence, women’s health, and combination treatments
MDedge ObGyn
Pregnancy outcomes on long-acting antiretroviral
MDedge ObGyn
Scientists create ‘vagina on a chip’: What to know
MDedge ObGyn
Doxy PEP does not lower risk of STIs in cisgender women
MDedge ObGyn
Perinatal HIV nearly eradicated in U.S.
MDedge ObGyn
Low HIV levels linked to ‘almost zero’ risk of sexual transmission
MDedge ObGyn